Exact Therapeutics H1 Operating Loss Widens To NOK 45.9 Million

RefinitivMeno di 1 minuto di lettura

Exact Therapeutics AS EXTX:

EXACT THERAPEUTICS FIRST HALF 2025 INTERIM RESULTS
H1 OPERATING LOSS NOK 45.9 MILLION VERSUS NOK 29.7 MILLION YEAR AGO

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Accedi o crea un account gratuito per leggere queste notizie